PRALATREXATE
Manner of administration:Injection
Restriction
Indication: Relapsed or chemotherapy refractory Peripheral T-cell Lymphoma
Treatment phase: Initial treatment
Quantities & Cost
| Max amount | # of repeats | DPMA | Max safety net | General Patient Charge |
|---|---|---|---|---|
| Max amount: 80 mg | # of repeats: 5 | DPMA: $4,336.90 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | ||||
| Folotyn
(pralatrexate 20 mg/mL injection, 1 mL vial)
|
||||
Manner of administration:Injection
Restriction
Indication: Relapsed or chemotherapy refractory Peripheral T-cell Lymphoma
Treatment phase: Continuing treatment
Quantities & Cost
| Max amount | # of repeats | DPMA | Max safety net | General Patient Charge |
|---|---|---|---|---|
| Max amount: 80 mg | # of repeats: 11 | DPMA: $4,233.23 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | ||||
| Folotyn
(pralatrexate 20 mg/mL injection, 1 mL vial)
|
||||
Manner of administration:Injection
Restriction
Indication: Relapsed or chemotherapy refractory Peripheral T-cell Lymphoma
Treatment phase: Continuing treatment
Quantities & Cost
| Max amount | # of repeats | DPMA | Max safety net | General Patient Charge |
|---|---|---|---|---|
| Max amount: 80 mg | # of repeats: 11 | DPMA: $4,336.90 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | ||||
| Folotyn
(pralatrexate 20 mg/mL injection, 1 mL vial)
|
||||
Manner of administration:Injection
Restriction
Indication: Relapsed or chemotherapy refractory Peripheral T-cell Lymphoma
Treatment phase: Initial treatment
Quantities & Cost
| Max amount | # of repeats | DPMA | Max safety net | General Patient Charge |
|---|---|---|---|---|
| Max amount: 80 mg | # of repeats: 5 | DPMA: $4,233.23 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | ||||
| Folotyn
(pralatrexate 20 mg/mL injection, 1 mL vial)
|
||||
